AI-driven Medicare Program Faces Scrutiny Over Denial Rates

An AI-driven program designed to streamline care approvals for Medicare beneficiaries in six U.S. states is drawing scrutiny over high denial rates and operational glitches.

The Wasteful and Inappropriate Service Reduction (WISeR) model, targeting cost reduction and administrative efficiency, has encountered significant challenges according to a lawsuit filed by the Electronic Frontier Foundation (EFF) against the Centers for Medicare & Medicaid Services (CMS). Critically, the litigation exposed systemic issues including high initial denial rates by the vendor Virtix Health, who administers operations in Washington state. Although a corrective plan has since improved Virtix Health's compliance, the situation highlights broader concerns about the model's efficacy and implications for Medicare participants.

Impact on Medicare Beneficiaries

WISeR's pilot program impacts 6.4 million Medicare users across New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. The initiative requires additional scrutiny for specific medical procedures prone to fraud, waste, and abuse, a process that critics argue delays timely care. Lena Cohen of the EFF points out significant delays, extending well beyond the expected response timeframes, sparking fears about adverse health outcomes due to deferred services.

Operational and Strategic Concerns

The program's deployment since January uncovered readiness challenges, with vendors like Innovaccer citing evolving requirements and inadequate testing timelines. Such operational complexities raise doubts about the scalability of the AI-driven model within traditional Medicare, which typically has fewer prior authorization requirements than Medicare Advantage plans. Stakeholders remain vigilant about potential impacts on patient care accessibility and the program’s ability to prevent fraud effectively.

Financial and Compliance Framework

Financially, vendor payments under WISeR are tied to decision quality metrics, ostensibly to reduce inappropriate denials. However, EFF claims these financial penalties are insufficient to ensure vendor accountability. As the program evolves, careful monitoring will be essential to gauge its impact on service quality, claims management, and Medicare's broader regulatory landscape.